IA Interviews: Michael Geranen of Captura Biopharma

by Innovate Arkansas May 29, 2020 Clients

David Sanders, Director of Innovate Arkansas (IA) at Winrock interviews Michael Geranen, CEO of Captura Biopharma about the company’s lead product that acts as a decorporation agent to be given to individuals that have been exposed to radiation, such as may occur in a nuclear power accident or detonation of a “dirty bomb”. This product would be the first oral solution that can immediately be administered to eliminate harmful radioactive material from staying in the body. Learn more about the work that Captura Biopharma is doing at https://www.capturabiopharma.com/

Share this article

About the author

Innovate Arkansas, is a state-funded initiative that helps scale promising Arkansas technology ventures. It assists technology entrepreneurs in turning startup companies into viable commercial enterprises. As a result of Innovate Arkansas' programming, the state of Arkansas has benefited from the launch of more than 100 startup companies, the creation of more than 600 Arkansas jobs, a sizable $226 million in revenue generated by these growing ventures, and a total of $265 million raised by our clients in private investment, public investment, and federal grants.

IA Interviews: Michael Geranen of Captura Biopharma

Share this article

About the author

Tags